Therefore, it appears that potentiating the Pparg signal in SAT is the primary cause to drive the fat deposition in AT, as well as other ectopic depots, which subsequently lead to metabolic disorders, including dyslipidemia and hyperglycemia in females, upon the loss of ovarian function. This evidence concerns the gene PPARG and metabolic disease.